Kezar Life Sciences, Inc.KZRNASDAQ
Loading
Operating Expenses Over TimeContracting
Percentile Rank67
3Y CAGR-2.8%
5Y CAGR+9.5%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
-2.8%/yr
vs +30.2%/yr prior
5Y CAGR
+9.5%/yr
Recent deceleration
Acceleration
-33.1pp
Decelerating
Percentile
P67
Within normal range
vs 5Y Ago
1.6x
Solid growth
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $65.28M | -28.0% |
| 2024 | $90.61M | -23.5% |
| 2023 | $118.42M | +66.4% |
| 2022 | $71.16M | +33.9% |
| 2021 | $53.15M | +28.2% |
| 2020 | $41.46M | +13.1% |
| 2019 | $36.68M | +48.3% |
| 2018 | $24.73M | +182.6% |
| 2017 | $8.75M | -2.7% |
| 2016 | $8.99M | - |